Companies: 10,795·Total market cap: $144.5T
Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc.

EKSONASDAQHealthcare
$11.80
+$0.15(+1.29%)
Market Cap$28625502
P/E Ratio
52W High$13.5
52W Low$2.73

Ekso Bionics Holdings, Inc. (EKSO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ekso · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 4 Wall Street analysts in the past 3 months

SellBuy

Buy

4 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
Total: 4 · Buy rate: 75.0%

12-Month Price Target

High

$6.00

Consensus

$3.50

-70.3% upside

Low

$1.00

Median: $3.5 · Last Close: $11.80

The Ekso Bionics Holdings, Inc. (EKSO) analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month EKSO price target is $3.50, representing -70.3% upside from the current price of $11.80.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $4 (-70.3%)

Consensus Target

$3.50

-70.3% upside

High Target

$6

-49.2%

Low Target

$1

-91.5%

Current Price

$11.80

as of today

Based on analyst price targets, the EKSO stock price prediction for the next 12 months ranges from $1 to $6. The consensus EKSO price forecast of $3.50 implies -70.3% upside from the current price of $11.80.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$12.395.00%

1-day model range: $12.28–$12.5. Peak: $12.5 (+5.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

64%36%0%
9Buy
5Neutral
0Sell
RSI (14)68.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · EKSO · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$11.74BUY
MA 10$11.45BUY
MA 20$10.69BUY
MA 50$10.67BUY
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $EKSO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$11.67BUY
EMA 10$11.43BUY
EMA 20$11.06BUY
EMA 50$10.51BUY
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $EKSO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2025-12-31
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2025-11-18
Maintains
BuyBuy
Lake Street2025-07-29
Maintains
BuyBuy
HC Wainwright & Co.2025-05-06
Maintains
BuyBuy
Lake Street2025-03-04
Maintains
BuyBuy
HC Wainwright & Co.2025-03-04
Maintains
BuyBuy
HC Wainwright & Co.2025-01-14
Maintains
BuyBuy
HC Wainwright & Co.2024-10-29
Maintains
BuyBuy
Lake Street2024-10-29
Maintains
BuyBuy
HC Wainwright & Co.2024-07-30
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Ekso Bionics Holdings, Inc. (EKSO) stock. Of the recent 24 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover EKSO.

Analyst Recommendation Trends

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

EKSO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$19M

↓ 36.6% YoY

Revenue Next Year

$24M

↑ 25.9% YoY

EPS This Year

$-0.10

EPS Next Year

$-0.06

↓ 41.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EKSO EPS of $-0.10 for the current fiscal year, based on estimates from 1 analysts. The EKSO revenue forecast is $19M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The EKSO stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EKSO price target is $3.50 (-70.3% upside), with an analyst consensus of Buy.

The EKSO short-term stock prediction for tomorrow is $12.39 (+5.00%).

Ekso Bionics Holdings, Inc. trades on NASDAQ under the ticker EKSO. The EKSO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

EKSO forecast · 8 questions

According to 4 Wall Street analysts, the average 12-month EKSO price target is $3.50, with a high forecast of $6.00 and a low of $1.00. The median price target is shown in the chart above when available. This implies -70.3% potential upside from the current price of $11.80.

EKSO price targetWhat is EKSO price targetEKSO analyst price targetEKSO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.